Industry Wire 276

  1. HHS cancels funding for Moderna’s H5 avian flu vaccine.
  2. Common herbal supplements could be linked to liver damage.
  3. Omada Health begins IPO, wants $1.1B valuation.
  4. Hinge Health’s IPO reignites digital health optimism.
  5. How provider collaborations are cutting hospital readmissions.
  6. Healthcare leaders rethinking strategy amid market volatility.
  7. Express Scripts, CVS sue Arkansas over PBM pharmacy ownership ban.
  8. ‘Night float’ schedule boosts radiologist productivity.
  9. Can a nasal spray slow down Alzheimer’s?
  10. Best Buy restructures its health unit.
Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

You might also like..

Select All

You're signed up!

It's great to have you as a reader. Check your inbox for a welcome email.

-- The Cardiac Wire Team

You're all set!